Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005–2008

Download Article

DOI: 10.21522/TIJNR.2015.02.01.Art015

Authors : Ranjana Prabhu


The following review is an attempt to critically analyses the article ‘Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005–2007’ first published in the Medical Journal of Australia in 2009. The article is by local Fijian authors and highly relevant as acute rheumatic fever (ARF) and rheumatic heart disease (RHD) contribute highly to the burden of disease in Fiji. The mentioned diseases also contribute greatly to admission numbers and mortality in third world countries like Fiji and are always regarded as areas of special interest as these diseases are virtually extinct in developed countries with NZ and Australia being exceptions. A thorough summary of the article will be provided and this will be followed by analysis of the article’s structure with critique of how the information is set out and whether the findings are efficiently imparted to the interested reader. The review also sets to critique the content mainly with regards to accuracy, objectivity, general coverage and evaluation of its authority. It also explores the author credibility and their insights into the need for such a research. Overall, the topic was a well-chosen one and the article itself is well written, concise and extremely relevant. 


[1.] Steer AC, Kado J, Jenney AW, Batzloff M, Waqatakirewa L, Mulholland EK and Carapetis J.( 2009).Acute Rheumatic Fever and Rheumatic Heart Disease in Fiji: prospective surveillance, 2005–2007, Medical Journal of Australia, vol 190:133-135,

[2.] Carapetis JR, Steer AC, Mulholland EK, Weber M, (2005). The global burden of group A streptococcal diseases. Lancet Infect Disease, vol 5: 685-694,

[3.] Carapetis JR, Currie BJ, (2001). Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever. Archives of Disease in Childhood, vol 85: 223-227,

[4.] Seckeler, M. D., & Hoke, T. R. (2011). The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clinical Epidemiology, vol 3: 67–84. doi:10.2147/CLEP.S12977,

[5.] Gray C, Thomson N (2013) Review of acute rheumatic fever and rheumatic heart disease among Indigenous Australians. Retrieved [20 August 2015] from

[6.] Kumar, R. K., & Tandon, R. (2013). Rheumatic fever & rheumatic heart disease: The last 50 years. The Indian Journal of Medical Research, vol 137(4), 643–658.

[7.] Viali S. (2006) Rheumatic fever and rheumatic heart disease in Samoa. Pacific Health Dialogue, vol 2:31-38.

[8.] Cunningham, M. W. (2012). Streptococcus and rheumatic fever. Current Opinion in Rheumatology, vol 24(4), 408–416.

[9.] Marijon E, Mirabel M, Celermajer DS, Jouven X. (2012) Rheumatic heart disease. The Lancet, vol 10:379(9819):953-64.

[10.] Viali S1, Saena P, Futi V. (2011) Rheumatic Fever Programme in Samoa. The New Zealand Medical Journal, vol 124: 26-35.

[11.] Henningham A, Gillen CM, Walker MJ. (2013). Group a streptococcal vaccine candidates: potential for the development of a human vaccine. Current Topics in Microbiology and Immunology, vol 368:207-242.